Research theme for competitive and other funds (9):
2022 - 2025 Construction of a hybrid peer support operation system for quality assurance of cancer peer support
2013 - 2016 Identification of factors of total QOL and satisfaction in cancer patients
2010 - 2012 An Interdisciplinary Study of Patient Clothes Using Arimatsu-Narumi Shiborithat Contributes to Easy Removability and Recovery Willingness
2007 - 2009 Development of novel treatment strategy against Hodgkin lymphoma based on the immunopathogenesis
2005 - 2009 The scientific clinical study of antibody therapy
2004 - 2006 Molecular-based study for the development of monoclonal antibody therapy in chemokine receptors, CCR4 and CXCR3
1999 - 2001 Clinical and biological analysis of familial essential thrombocythemia
がん薬物療法患者における科学的QOL評価による実地医療への有効な支援法の同定
家族性血小板血症の発症機序の分子生物学的解明
Show all
Papers (73):
Yoshihiko Tasaki, Yosuke Sugiyama, Shuzo Hamamoto, Taku Naiki, Takehiro Uemura, Keisuke Yokota, Daisuke Kawakita, Motoki Nakamura, Ryo Ogawa, Takaya Shimura, et al. Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study. Cancer medicine. 2023
Yuko Yamamoto, Masahiro Kondo, Yuji Hotta, Yuusuke Tashiro, Akimasa Sanagawa, Tomaya Kataoka, Yoko Furukawa-Hibi, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida, et al. The Relationship between Changes in Serum Element Concentrations and Pathological Condition and Disease Status in Japanese Multiple Myeloma Patients: A Pilot Study and Literature Review. Asian Pacific journal of cancer prevention : APJCP. 2023. 24. 7. 2493-2503
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, Hiroya Hashimoto, Nozomi Nishitarumizu, Yoko Nakanishi, Yukiyasu Kato, Akimi Kawai, Naohiro Matsunaga, Toru Ebina, et al. A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma. International journal of hematology. 2023. 117. 6. 900-909
Tomoko Narita, Masaki Ri, Shiori Kinoshita, Takashi Yoshida, Haruhito Totani, Reham Ashour, Ayako Masaki, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, et al. Identification of Circulating Serum microRNAs As Novel Biomarkers Predicting Disease Progression and Sensitivity to Bortezomib Treatment in Multiple Myeloma. BLOOD. 2016. 128. 22
Haruhito Totani, Shigeru Kusumoto, Takashi Ishida, Asahi Ito, Masaki Ri, Hirokazu Komatsu, Ryuzo Ueda, Yasuhito Tanaka, Akio Niimi, Shinsuke Iida. REACTIVATION OF HEPATITIS B VIRUS (HBV) IN HBV-RESOLVED PATIENTS WITH ADULT T-CELL LEUKEMIA/LYMPHOMA. ANNALS OF ONCOLOGY. 2014. 25
Tomohiro Nakaguchi, Toru Okuyama, Megumi Uchida, Yoshinori Ito, Hirokazu Komatsu, Makoto Wada, Tatsuo Akechi. ONCOLOGY NURSES' RECOGNITION OF SUPPORTIVE CARE NEEDS AND SYMPTOMS OF THEIR CANCER PATIENTS UNDERGOING CHEMOTHERAPY. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. 2012. 8. 245-245
Masaki Ri, Etsu Tashiro, Daisuke Oikawa, Satoko Shinjo, Mio Tokuda, Yumi Yokouchi, Tomoko Narita, Ayako Masaki, Fumiko Mori, Asahi Ito, et al. Identification of Toyocamycin, an Agent Cytotoxic for Multiple Myeloma Cells, As a Potent Inhibitor of ER Stress-Induced XBP1 mRNA Splicing. BLOOD. 2012. 120. 21
Atsushi Inagaki, Takashi Ishida, Hiroki Yano, Fumiko Mori, Asahi Ito, Masaki Ri, Jianmin Ding, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida, et al. Expression of the ULBP Ligands for NKG2D by B-NHL Cells Plays An Important Role in Determining Their Susceptibility to Rituximab-Induced ADCC. BLOOD. 2008. 112. 11. 87-88